Connect with us

Medication

The man who died after taking antibiotics did not warn of the danger

Published

on

A disabled man who died of lung disease caused by long-term use of an antibiotic should have been warned of the danger, a health expert has found.

In a recently released report, Deputy Health and Disability Commissioner Carolyn Cooper found several health professionals missed opportunities to make sure the man understood the risk of taking the antibiotic nitrofurantoin for months more than six.

The man, who had been paralyzed for several years before the accident, was given the drug for the first time in 2017 to treat common bladder infections by a specialist at the community hospital’s spine center.

He took nitrofurantoin for about 28 months over three years, before dying of pulmonary fibrosis – a rare side effect of long-term antibiotic use.

Advertisement

Subsequently, his wife complained about this care against several health care providers, including a chiropractor at a spine center, a medical center, her GP, a chemist and a department of urology in a community hospital elsewhere.

«In completing this research, I agree and support his desire to prevent any preventable death that may be caused by the negative effects of nitrofurantoin,» Cooper said.

He found health professionals «share responsibility for missed opportunities» to warn men of harm.

«While I am very concerned that none of the health care providers who cared for the man made sure he understood the risks, I believe that no one person or service has a lot of responsibility,» he said.

«All health care providers who had a role in ordering and administering nitrofurantoin to that man should have assessed whether he knew the long-term risk at the appropriate time,» and that this did not happen.»

Advertisement

A specialist at the spine center told the HDC that he «remembered» notifying the patient in July 2017 of the injury, but admitted there was no record of this conversation.

Other providers – including a GP and urology registrar at another hospital – continued to offer it in the coming months and years until 2019.

The man’s wife told HDC that after taking nitrofurantoin for about six to eight months, her husband developed a mild and dry cough, but since they had unaware that this may be related to nitrofurantoin, they did not raise any concerns about this. at that time.

The government’s drug safety agency, Medsafe, first announced the risk of adverse lung effects associated with the use of nitrofurantoin back in 2002, and again in 2012.

However, the GP said he was unaware of the risk of lung damage at the time.

Advertisement

«If I had known about the serious long-term side effects of these medications, I certainly would have done a risk/benefit analysis.»

The secretary of urology said that when he saw a patient, he was doing an unsupervised clinical procedure with limited time for serious medical discussions or great support.

«I was disappointed when I heard [Mr A’s] death. Any part that I have played in this process is very frustrating for me. I feel responsible for this and I am very upset that my interaction with him was not the small moment that was needed to change his path from an early death.

«This explanation is difficult for me to accept, however, it is tempered by the fact that I was not the doctor who started the prophylaxis using nitrofurantoin, and also my knowledge that the patient was and under the continuous supervision of a urologist in private practice [another region].»

A pharmacy consultant told the HDC that the pharmacy should have informed the patient of the potential risk, but admitted there was a feeling among some in the profession that «time pressure and cost » doesn’t allow that type of element.

Advertisement

The pharmacist told the HDC: «As a community pharmacist, you have to trust that the doctor has made a conscious decision to start a patient on long-acting nitrofurantoin after weighing the risks and benefits, especially if they they’re taking a lot of short-term courses.»

Cooper said the complaint revealed that some doctors were unaware of the potential for serious lung damage from long-term use of nitrofurantoin.

«It shed light on a very important issue and encouraged the necessary reforms and education to reduce the chances of a similar situation in the future,» he said.

In response to the crisis, relevant donors had already made changes.

These include a request made by the pharmacy to the Pharmacy Safety Association to request the distribution of relevant information to all community pharmacists.

Advertisement

The backbone is creating an information document that will be shared with the Royal New Zealand College of General Practitioners (RNZCGP).

The medical center has done an examination of all the patients given this medicine for diagnosis and to make sure that the side effects are repeated in them.

#man #died #antibiotics #warn #danger

Continue Reading
Advertisement
Click to comment

Leave a Reply

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Medication

5WPR Expands Health and Wellness Divide with New Focus on Functional Nutrition

Published

on

By

5WPR Expands Health and Wellness Divide with New Focus on Functional Nutrition

Strengthening Capacity to Support Growing Demand in the Functional Food Sector

NEW YORK, December 3, 2024 /PRNewswire/ — 5WPR, one of America’s leading and largest independent PR firms, is proud to announce the expansion of its Health & Wellness division to include focusing on Functional Nutrition. This strategic move reflects 5W’s commitment to staying ahead of industry trends and evolving its services to meet the needs of this rapidly changing market.

5W Brand (PRNewsfoto/5W Public Relations)
5W Brand (PRNewsfoto/5W Public Relations)

With increasing consumer interest in functional foods, brands are seeking expert guidance to differentiate themselves in a competitive market. In response, 5WPR has expanded its services to cover key areas within the nutrition industry, including gut health, supplements and functional drinks, performance and sports nutrition, protein powder, probiotics, weight management, collagen peptides, dietary powder, functional mushrooms. , nutrition, and pet health.

Functional nutrition has become an influence in the field of health and wellness, fueled by increased consumer awareness and demand for products that provide more than basic nutritional benefits. According to the latest data from Open PR, gut health products alone are estimated to grow by approximately 8% annually between 2024 and 2031. Additionally, the Food Institute is report that e-commerce has emerged as the fastest growing channel for supplements in 2023, an increase of 9.5%, highlighting the importance of a strong online presence. Performance nutrition has also seen significant growth, with categories such as hydration and electrolytes increasing by 52.2%, and creatine sales increasing by an impressive 114.4%, according to the New Hope Network.

«The functional nutrition market is not only growing; it is defining the health and wellness industry,» he said. Ilisa WirginManaging Partner and EVP of 5WPR’s Health & Wellness and Beauty division. «Consumers are looking for products that improve their overall well-being, improve performance, and support recovery, which makes it an exciting and exciting segment. Our expanded focus will help us helping customers in this area to grow their product profiles, align with their target audience, and deliver meaningful results.»

Advertisement

5WPR’s track record in health and wellness includes working with some of the most recognized brands in fitness, nutrition, and personal care. The agency’s expertise in media relations, influencer partnerships, thought leadership, digital strategy, and affiliate marketing ensures that clients in the nutrition space receive structured, comprehensive, and measurable support.

#5WPR #Expands #Health #Wellness #Divide #Focus #Functional #Nutrition

Continue Reading

Medication

Lady Gabriella’s husband ‘killed himself after taking antidepressants’

Published

on

By

Thomas Kingston and Lady Gabriella Kingston after their wedding at St George's Chapel in Windsor in 2019.

Your support helps us tell the story

From reproductive rights to climate change to Big Tech, The Independent is breaking new ground as the story unfolds. Whether it’s investigating Elon Musk’s pro-Trump PAC funding or presenting our latest article, ‘The A Word’, which shines a light on American women fighting for reproductive rights, we know how How important is clarity in messages.

At such a critical time in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to talk to both sides of the story.

The Independent is trusted by Americans across all political lines. And unlike many other quality publications, we choose not to block Americans from reporting and reviewing through paywalls. We believe that quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Lady Gabriella Kingston’s husband took his own life after taking anti-depressants prescribed by his doctor, a coroner has said.

Advertisement

Thomas Kingston, who married Prince and Princess Michael of Kent’s daughter at Windsor Castle in 2019, died of a head injury and a gun was found next to his body on March 25 at his parents’ home in the Cotswolds.

At an inquest into her death held at Gloucestershire Coroner’s Court on Tuesday, Lady Gabriella, 43, asked people to be warned about the side effects of drugs used to treat mental health conditions or she feared people would many may die.

The inquest was told that the 45-year-old fundraiser had been given sertraline, a drug used to treat depression, and zopiclone, a sleeping pill, by a doctor at the Royal Mews Surgery, Buckingham Palace’s staff-run practice. of the palace. , after complaining of trouble sleeping after stress at work.

Mr Kingston went back to surgery saying they were not making him feel better, and his doctor switched him from sertraline to citalopram, a similar drug.

Thomas Kingston and Lady Gabriella Kingston after their wedding at St George's Chapel in Windsor in 2019.

Advertisement
Thomas Kingston and Lady Gabriella Kingston after their wedding at St George’s Chapel in Windsor in 2019. (PA Archives)

In the first days of his death, Mr. Kingston had stopped taking medication, and toxicology tests showed caffeine and a small amount of zopiclone in his system.

In a statement read out by Katy Skerrett, chief minister of Gloucestershire, Lady Gabriella, 43, said: «[Work] it has been a challenge for her over the years but I highly doubt it would have made her suicidal, and she seemed to have improved a lot.

If there was something that was bothering him, I’m sure he would have said that he was struggling a lot.

The fact that he committed suicide in the home of his beloved parents suggests that the decision was the result of a sudden impulse.

He said he believed her death «may have been precipitated» by an adverse reaction to medication she had started, and then stopped, taking in the weeks leading up to her death.

Advertisement

«In the absence of any evidence of propensity, it seems very likely to me that she had a bad reaction to the pills that made her take her own life,» Lady Gabriella said.

Thomas Kingston and Lady Gabriella Kingston arrive at the Thanksgiving service for Prince Philip at Westminster Abbey in 2022.

Thomas Kingston and Lady Gabriella Kingston arrive at the Thanksgiving service for Prince Philip at Westminster Abbey in 2022. (AFP via Getty Images)

«I believe that anyone who takes pills like these should be warned about the side effects to prevent future deaths.

If this can happen to Tom, it can happen to anyone.

In his final weeks, Mrs Gabriella said, her husband «seemed normal», except for the morning after he first took zopiclone, which she said made him seem «he he’s a bit confused».

Advertisement

In his statement, he described their marriage as one of «deep love and trust» and said he never gave any suicidal thoughts to himself or others.

He also said he was deeply affected by his friend’s suicide and «the negative impact it had on other people’s loved ones».

Miss Gabriella, whose wedding to Mr Kingston included Queen Elizabeth II and the late Duke of Edinburgh among the guests, wept as she sat in the coroner’s court as her statement was read.

Thomas Kingston died of a head injury and a gun was found next to his body on February 25 at his parents' home in the Cotswolds.

Thomas Kingston died of a head injury and a gun was found next to his body on February 25 at his parents’ home in the Cotswolds. (PA Archives)

Wrapping up the story, Ms Skerrett said: «Mr Kingston took his own life with a self-inflicted gunshot wound to the head.

Advertisement

«The evidence of his wife, family and business partner all support the lack of intent to kill himself.

He was suffering from the side effects of the medicine he had just been given.»

He said he intends to make a report on the prevention of future deaths, which will be sent to medical societies.

Mr. Kingston’s father, William Martin Kingston, wept as he described finding his son in the locked bathroom of the annexe, having used a doorknob to break the door.

He told the court that his son has always had a strong, unstable character, as he previously suffered from pain that left him needing help to climb the stairs.

Advertisement

She told the coroner that before her son’s death there did not appear to be any evidence of suicide, and there was no will, describing the process as «reckless.» very» who was «out of shape».

Dr David Healy, a psychiatrist who gave evidence at the hearing, said zopiclone could also cause anxiety, while sertraline and citalopram were both serotonin reuptake inhibitors (SSRIs), and while exactly the same.

Dr Healy said Mr Kingston’s complaints that sertraline continued to cause him anxiety was a sign SSRIs «didn’t suit him», and he should not have been prescribed the same thing again.

He said the guidelines and labels for SSRIs were not clear enough about using the drug first, or what the effect would be when switching from one to another.

He said: «We need a clearer statement that these drugs can cause people to kill themselves who would otherwise not kill themselves.

Advertisement

Speaking to the doctor, Martin Porter, the family’s adviser, said: «The family is not to blame (her doctor) Dr Naunton Morgan, he worked like a good doctor.

But the question is whether there is enough advice to doctors about SSRIs.

#Lady #Gabriellas #husband #killed #antidepressants

Continue Reading

Medication

AlayaCare’s Cloud-Based EHR Platform Onboards Home Care Benefits of the Home Care Center

Published

on

By

AlayaCare's Cloud-Based EHR Platform Onboards Home Care Benefits of the Home Care Center

AlayaCare Inc.
AlayaCare Inc.

AlayaCare’s Cloud-Based EHR Platform Onboards Home Care Benefits of the Home Care Center

AlayaCare has successfully partnered with Care Advantage, the largest home health care provider in the mid-Atlantic, to implement a sustainable approach to improving care delivery in 50+ locations.
AlayaCare has successfully partnered with Care Advantage, the largest home health care provider in the mid-Atlantic, to implement a sustainable approach to improving care delivery in 50+ locations.

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) — AlayaCare, a global technology platform for home and community care, is pleased to announce today the successful implementation of Care Advantage, Inc.

Care Advantage, Inc. is the largest independent home health provider in the mid-Atlantic. The company provides personal services, home care and home health services throughout Virginia, Maryland, Delaware, North Carolina and Washington DC.

Care Advantage’s leadership recognized AlayaCare’s ability to provide a risk-free, user-friendly solution that could grow with the company. The decision to collaborate with AlayaCare was made after an extensive selection process that considered the opinions of experts from its internal teams, emphasizing the importance of a holistic approach to choosing a technology partner.

«We were looking for a partner, not just a vendor, who could help us build and transform our system over time,» said Tim Hanold, CEO of Care Advantage. «AlayaCare’s commitment to working together and creating a true partnership were key factors in our final decision.»

Despite the challenges presented by the published timeline and coverage of more than 50 locations, both teams worked closely to customize the system to meet Care Advantage’s needs.

Advertisement

«Implementing a system of this size in such a short period of time was no small feat,» said Jaron Clay, VP of Integrations. «The speed of the rollout was only possible with good coordination and both groups are committed to having Care Advantage running smoothly and feeling the benefits of the new system as soon as possible.»

The move to AlayaCare underscores Care Advantage’s commitment to innovation and excellence in home care, ensuring clients and their families receive the best possible care and support. As a highly data-driven and growth-focused company, the flexibility of AlayaCare’s platform enables large operations to enter new markets while maintaining a high level of customer care. own and create new opportunities for its custodians.

«There is a shared understanding and vision between us and the AlayaCare team,» said Tim Hanold. «They support our unwavering commitment to excellence in the classroom and are part of the reason we chose them. We feel this is the platform to take us to that level. We are delighted to have AlayaCare as a partner our technology,» he concluded. «Together, we’re setting new standards for home care.»

#AlayaCares #CloudBased #EHR #Platform #Onboards #Home #Care #Benefits #Home #Care #Center

Advertisement
Continue Reading

Trending

Copyright © 2017 Zox News Theme. Theme by MVP Themes, powered by WordPress.